Nationwide Analysis of Characteristics and Outcomes of Patients with Heparin Induced Thrombocytopenia Admitted for Treatment of COVID-19
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
Blood
Conference Name
ASH Annual Meeting
Conference Date
2023-12-09 - 2023-12-12
First Page
2661
DOI
10.1182/blood-2023-184713
Volume
142
Issue
Supplement 1
Publication Date
11-2-2023
Recommended Citation
Ammad Ud Din, M., Liaqat, H., Shahzad, M., Jaan, A., Osama, M., Farooq, M., & Jaglal, M. V. (2023). Nationwide Analysis of Characteristics and Outcomes of Patients with Heparin Induced Thrombocytopenia Admitted for Treatment of COVID-19. Blood, 142 (Supplement 1), 2661. https://doi.org/10.1182/blood-2023-184713
COinS